查看所有供应商和价格请点击:
1608108-91-3生产厂家
1608108-91-3价格
化源商城直购
[1]. AGertz M, et, al. Birtamimab in Patients with Mayo Stage IV AL Amyloidosis: Rationale for Confirmatory Affirm-AL Phase 3 Study Design. Journal home page for Blood. Volume 138, Supplement 1, 23 November 2021, Page 2754.